Management of hepatitis C in patients with chronic kidney disease

被引:0
|
作者
Roberto J Carvalho-Filho [1 ]
Ana Cristina CA Feldner [1 ]
Antonio Eduardo B Silva [1 ]
Maria Lucia G Ferraz [1 ]
机构
[1] Division of Gastroenterology,Hepatology Section,Federal University of Sao Paulo,Sao Paulo,SP 04023-900,Brazil
关键词
Hepatitis C virus; Chronic kidney disease; End-stage renal disease; Hemodialysis; Kidney transplantation; Diagnosis; Conservative management; Therapy;
D O I
暂无
中图分类号
R692 [肾疾病]; R512.63 [];
学科分类号
1002 ; 100210 ; 100401 ;
摘要
Hepatitis C virus(HCV) infection is highly prevalent among chronic kidney disease(CKD) subjects under hemodialysis and in kidney transplantation(KT) recipients, being an important cause of morbidity and mortality in these patients. The vast majority of HCV chronic infections in the hemodialysis setting are currently attributable to nosocomial transmission. Acute and chronic hepatitis C exhibits distinct clinical and laboratorial features, which can impact on managementand treatment decisions. In hemodialysis subjects, acute infections are usually asymptomatic and anicteric; since spontaneous viral clearance is very uncommon in this context, acute infections should be treated as soon as possible. In KT recipients, the occurrence of acute hepatitis C can have a more severe course, with a rapid progression of liver fibrosis. In these patients, it is recommended to use pegylated interferon(PEG-IFN) in combination with ribavirin, with doses adjusted according to estimated glomerular filtration rate. There is no evidence suggesting that chronic hepatitis C exhibits a more aggressive course in CKD subjects under conservative management. In these subjects, indication of treatment with PEG-IFN plus ribavirin relies on the CKD stage, rate of progression of renal dysfunction and the possibility of a preemptive transplant. HCV infection has been associated with both liver disease-related deaths and cardiovascular mortality in hemodialysis patients. Among those individuals, low HCV viral loads and the phenomenon of intermittent HCV viremia are often observed, and sequential HCV RNA monitoring is needed. Despite the poor tolerability and suboptimal efficacy of antiviral therapy in CKD patients, many patients can achieve sustained virological response, which improve patient and graft outcomes. Hepatitis C eradication before KT theoretically improves survival and reduces the occurrence of chronic graft nephropathy, de novo glomerulonephritis and post-transplant diabetes mellitus.
引用
收藏
页码:408 / 422
页数:15
相关论文
共 50 条
  • [31] Treatment of Chronic Hepatitis C in Patients With Chronic Kidney Disease and End Stage Renal Disease: A Case Series
    Mannam, Sunitha
    Habib, Shahid
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S695 - S695
  • [32] Hepatitis C treatment in patients with kidney disease
    Fabrizi, Fabrizio
    Aghemo, Alessio
    Messa, Piergiorgio
    [J]. KIDNEY INTERNATIONAL, 2013, 84 (05) : 874 - 879
  • [33] Simultaneous Liver/Kidney Transplantation for Hepatitis C Positive Patients with Chronic Kidney Disease: Are Kidney Allografts Worthwhile?
    Hibi, T.
    Nishida, S.
    Sageshima, J.
    Tekin, A.
    Selvaggi, G.
    Levi, D.
    Uchida, K.
    Chen, L.
    Ciancio, G.
    Ruiz, P.
    Burke, G. W.
    Tzakis, A. G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 510 - 510
  • [34] Hepatitis C and kidney disease:An overview and approach to management
    Ahmad Najib Azmi
    Soek-Siam Tan
    Rosmawati Mohamed
    [J]. World Journal of Hepatology, 2015, (01) : 78 - 92
  • [35] Hepatitis C and kidney disease: An overview and approach to management
    Azmi, Ahmad Najib
    Tan, Soek-Siam
    Mohamed, Rosmawati
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (01) : 78 - 92
  • [36] Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
    Ko, Soon Young
    Choe, Won Hyeok
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2018, 24 (04) : 351 - 357
  • [37] Management of patients with chronic kidney disease in the setting of interferon-free treatment for chronic HCV hepatitis
    Iliescu, E. L.
    Ioanitescu, S.
    Toma, L.
    Ureche, M. B.
    Mercan-Stanciu, A.
    Iancu, C.
    Dodot, M.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S260 - S261
  • [38] THE IMPACT OF HEPATITIS C VIRUS ON KIDNEY-RELATED OUTCOMES AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE
    Rodriguez, C., V
    Arduino, J.
    Hsu, J.
    Rubenstein, K. B.
    Wei, R.
    Hu, H.
    Horberg, M.
    Derose, S.
    Tartof, S. Y.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A129 - A129
  • [39] Management of patients with chronic hepatitis C infection
    S. K. Herrine
    S. Rossi
    V. J. Navarro
    [J]. Clinical and Experimental Medicine, 2006, 6
  • [40] Treatment of hepatitis B in patients with chronic kidney disease
    Pipili, Chrysoula L.
    Papatheodoridis, George V.
    Cholongitas, Evangelos C.
    [J]. KIDNEY INTERNATIONAL, 2013, 84 (05) : 880 - 885